Clinical trial

A Probiotic Strategy for Antipsychotic-induced Metabolic Dysfunction

NCT06729671

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2024-05-16

PhaseNA

Study timeline

Study start (actual)2024-05-16Date precision: day

Registry last updated2024-12-11

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Psychosisverified · MONDO: psychotic disorder

Interventions

Bifidobacterium longum APC1472 hydroxypropylmethylcellulose (HPMC) capsuleDIETARY_SUPPLEMENT

maltodextrinDIETARY_SUPPLEMENT

Sponsors & collaborators

University College Corklead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06729671 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.